Medtronic (NYSE: MDT) is entering the final stretch of its long-running plan to split from its diabetes technology business, with the launch of an exchange offer that will allow stockholders to swap their company shares for those of the independent MiniMed (Nasdaq: MMED). With its catalog of insulin pumps, continuous glucose monitors and other diabetes […]
Medtronic
MiniMed has a new board member following Brett Wall’s Medtronic departure
MiniMed (Nasdaq:MMED) announced the appointment of Scott Cundy to its board of directors, effective July 3, 2026. Cundy’s appointment comes in the wake of Brett Wall’s departure from MiniMed parent company, Medtronic, announced this week. Wall, the EVP and president of the Medtronic Neuroscience portfolio, served as a class II director for MiniMed and as […]
MiniMed not aware of compromises, doesn’t expect impact from Medtronic cyber breach
MiniMed (Nasdaq:MMED) issued an SEC filing stating that it doesn’t expect to be affected by the recent cybersecurity breach at parent company Medtronic. On April 24, Medtronic issued a statement saying that it determined that an unauthorized party accessed data in certain corporate IT systems. The company identified no impact to products, patient safety, connections to […]
Medtronic has strong 1-year results for drug-coated balloon
Medtronic (NYSE:MDT) today announced new real-world data from a post-approval study of its In.Pact AV drug-coated balloon (DCB). The IN.PACT AV Access post-approval study demonstrated strong safety and effectiveness for the DCB in the treatment of arteriovenous fistula (AVF) stenoses in patients with end-stage kidney disease on dialysis. The study sought to expand real-world experience through […]
MiniMed flexes with next-gen insulin pump after spinning off from Medtronic
MiniMed Chief Product and Technology Officer Ali Dianaty explains how the former Medtronic Diabetes unit used patient feedback to develop its latest automated insulin delivery innovation.
Within two weeks of MiniMed’s initial public offering in March, the Medtronic spinoff received FDA clearance for its latest-generation MiniMed Flex automated insulin delivery system. The smaller, screenless pump system is a major milestone for one of the world’s largest diabetes businesses. “We have a long history with durable pumps,” MiniMed EVP, Chief Product and Technology Officer, Ali Dianaty said in […]
FDA labels MiniMed insulin pump recall Class II
The FDA recently published a Class II recall related to insulin pump systems made by MiniMed (Nasdaq:MMED). Class II recalls constitute a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. MiniMed is […]
Analysts initiate MiniMed with ‘Buy’ rating in competitive diabetes tech space
BTIG analysts today opened coverage for MiniMed (Nasdaq:MMED) with optimism about the company’s scale, reach and potential pipeline. Marie Thibault, Alexandra Pang and Sam Eiber initiated MiniMed with a “Buy” rating following the Medtronic Diabetes business’ recent initial public offering (IPO), despite the IPO coming up short of its initial target price. “Our MiniMed Group […]
Medtronic cuts 2026 guidance on private equity charge related to MiniMed approval
Medtronic (NYSE:MDT) said in an SEC filing that it lowered its full-year guidance after a one-time charge related to its MiniMed diabetes unit. Last week, MiniMed announced FDA clearance for the MiniMed Flex, a next-generation automated insulin delivery system. Clearance came “several months earlier than anticipated,” according to the filing, facilitating earlier commercialization. R&D for […]
MiniMed wins FDA clearance for next-gen Flex insulin pump
MiniMed (Nasdaq:MMED) announced today that it received FDA clearance for the MiniMed Flex next-generation insulin pump. Flex, a discreet, smartphone-controlled insulin pump, was designed by the company — which just went public as part of its separation from Medtronic — to seamlessly fit into everyday life. Clearance covers individuals aged 7 and older with type […]
MiniMed picks up CE mark for MiniMed 780G pump with Instinct sensor made by Abbott
MiniMed (Nasdaq:MMED) announced today that it received CE mark for the use of its MiniMed 780G with the Instinct sensor made by Abbott. Northridge, California-based MiniMed — which just went public as part of its separation from Medtronic — now offers more sensor choices for users of its most advanced automated insulin delivery system. The […]
